BSV receives approval from DCGI to conduct phase III clinical study on Ulinastatin
As per approved clinical trial protocol, subjects with mild to moderate COVID-19 will be randomised in study in a 1:1 ratio with…
Recover your password.
A password will be e-mailed to you.
- Advertisement -
Recover your password.
A password will be e-mailed to you.